Genrix Biopharmaceutical and Chongqing Pharmaceutical Group Form Strategic Partnership to Boost Market Launch
Chongqing Genrix Biopharmaceutical Co., Ltd (SHA: 688443), a biopharmaceutical company based in China, has entered...
Deals
Grifols Completes Sale of 20% Stake in Shanghai RAAS to Haier Group for RMB 12.5 Billion
Grifols AS (NASDAQ: GRFS), a Spain-based global leader in the production of blood products, has...
3SBio Secures Long-Term Financing from IFC for Manufacturing and Global Expansion
3SBio Inc. (HKG: 1530), a biopharmaceutical company based in China, is slated to receive long-term...
Sanofi Partners with Belharra Therapeutics to Tap into Chemoproteomics for Immunology Targets
Sanofi (NASDAQ: SNY; EPA: SAN), a major French pharmaceutical company, has formed a collaboration with...
Day One Biopharmaceuticals Expands Pipeline with MabCare Therapeutics Licensing Deal
Day One Biopharmaceuticals (NASDAQ: DAWN), a California-based biotech company that recently celebrated its first drug...
Roche Secures RNA Exon Editing Tech for Neurological Diseases with Ascidian Deal
Roche (SWX: ROG; OTCMKTS: RHHBY), a Swiss pharmaceutical giant, is expanding its footprint in the...
Shineco Partners with Tuling Vision to Develop Intelligent Healthcare Solutions
Shineco Inc. (NSDQ: SISI), a U.S.-based company, has signed a partnership deal with China-headquartered Tuling...
Wuxi’s Binhu District Partners with Fresenius Kabi to Boost Healthcare Services
The Binhu District People’s Government of Wuxi, Jiangsu province, China, has entered into a partnership...
Sinovac Partners with Brazil’s Fiocruz to Boost Vaccine Research and Development
Fiocruz, a renowned health research center based in Brazil, has announced a collaboration agreement with...
CATUG Biotechnology Secures Nearly RMB 100 Million in Latest Financing Round to Expand Globally
CATUG Biotechnology, a cutting-edge company in the nucleic acid and gene therapy sector, has announced...
Neusoft IntelliRay Secures Over RMB 100 Million in Series C Funding Round
Neusoft IntelliRay Technology Co., Ltd, a medical technology company based in Shenyang, has successfully closed...
Takeda Secures Global Rights to Ascentage Pharma’s Olverembatinib Outside of China and Select Territories
Takeda Pharmaceuticals, a leading biopharmaceutical company based in Japan (TYO: 4502), has entered into an...
AbbVie Strikes Deal with FutureGen for Global Rights to Next-Gen TL1A Antibody FG-M701
AbbVie (NYSE: ABBV), a biopharmaceutical giant based in the US, has announced a licensing agreement...
BeiGene to Terminate Partnership with NewBridge Pharmaceuticals for MENA Region
BeiGene (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a leading biopharmaceutical company based in China, has...
Ethypharm Expands in China’s IBD Market with Acquisition of Mesalazine Suppository
Ethypharm, a France-based pharmaceutical company, has announced that its Chinese subsidiary, Shanghai Ethypharmaceuticals Ltd, has...
Sihuan’s Xuanzhu Biopharmaceutical Strikes Licensing Deal with Livzon Pharmaceutical for Fadanafil
Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has declared that its subsidiary, Xuanzhu Biopharmaceutical Co.,...
Ronovo Surgical Secures Over RMB 300 Million in Series B to Globalize Surgical Robot
Shanghai-based surgical robotics specialist, Ronovo Surgical, has reportedly raised over RMB 300 million (USD 41.3...
Cellbri Bio Secures Nearly RMB 200 Million in Series B Financing to Boost CGT Commercialization
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd, a prominent player in China’s cell and gene therapy...
Zhejiang Dian Diagnostics Partners with Quest Diagnostics to Advance Alzheimer’s Disease Blood Tests
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostics company based in China, has...
GSK Partners with Ochre Bio to Access Liver Data for Hepatology Therapy Development
GlaxoSmithKline (GSK; NYSE: GSK), a UK-based pharmaceutical giant, has entered into an agreement with fellow...